TSE:APHA

Aphria Stock Forecast, Price & News

C$16.55

-0.98 (-5.59 %)

(As of 05/4/2021)

Add

Compare

Today's Range

C$16.41

▼

C$17.52

50-Day Range

C$16.52

▼

C$22.79

52-Week Range

C$3.93

▼

C$40.93

Volume9.61 million shs

Average Volume6.16 million shs

Market CapitalizationC$5.24 billion

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter.

About Aphria

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Medical Cannabis Market Growth Sturdy at 23.9% CAGR to Outstrip $49116.4 Million by 2028 - GlobeNewswire
June 23, 2021 | globenewswire.com

Canadian Cannabis: What's Next For Tilray, Sundial, Aurora And More? - Benzinga
June 23, 2021 | benzinga.com

How Strong Is Tilray After the Aphria Merger? - Motley Fool
June 23, 2021 | fool.com

Top Stocks To Watch Today? 3 Marijuana Stocks For Your Watchlist - Nasdaq
June 18, 2021 | nasdaq.com

Is It Too Late to Buy Tilray Stock? - Motley Fool
June 17, 2021 | fool.com

Tilray Has Little Upside Left in 2021 After 33% Surge, Analyst Says - Nasdaq
June 12, 2021 | nasdaq.com

Aphria Inc. (TSE:APHA) Receives Average Rating of "Hold" from Brokerages
June 8, 2021 | americanbankingnews.com

Will This Colossal Mistake Send Canopy Growth Stock Crashing? - Motley Fool
June 8, 2021 | fool.com

Tilray, Inc. (TLRY) Announces Launch of New Medical Cannabis Brand, Symbios - StreetInsider.com
June 8, 2021 | streetinsider.com

Aphria (TSE:APHA) Stock Price Down 5.6%
June 5, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:APHA
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.aphria.com
Phone844-427-4742
Employees1,200
Year FoundedN/A

Sales & Book Value

Annual SalesC$611.06 million
Price / Sales8.58
Cash FlowC$0.74 per share
Price / Cash Flow22.40
Book ValueC$4.76 per share
Price / Book3.48

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares316,795,000
Market CapC$5.24 billion
Next Earnings Date7/27/2021 (Estimated)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.14 out of 5 stars

3.1 Analyst's Opinion

Consensus Rating
Aphria has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 1 buy rating, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$18.34, Aphria has a forecasted upside of 10.8% from its current price of C$16.55.
Amount of Analyst Coverage
Aphria has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.6 Community Rank

Outperform Votes
Aphria has received 381 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Aphria has received 358 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Aphria has received 51.56% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote “Outperform” if you believe APHA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Aphria does not currently pay a dividend.
Dividend Growth
Aphria does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aphria insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Aphria is -8.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aphria is -8.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Aphria has a P/B Ratio of 3.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Aphria (TSE:APHA) Frequently Asked Questions

Is Aphria a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
View analyst ratings for Aphria or view top-rated stocks.

What stocks does MarketBeat like better than Aphria?

Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Aphria.

How has Aphria's stock price been impacted by Coronavirus (COVID-19)?

Aphria's stock was trading at C$3.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APHA shares have increased by 349.7% and is now trading at C$16.55.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for APHA?

6 equities research analysts have issued 1 year price targets for Aphria's shares. Their forecasts range from C$10.75 to C$28.00. On average, they anticipate Aphria's stock price to reach C$18.34 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Aphria or view top-rated stocks among Wall Street analysts.

Who are Aphria's key executives?

Aphria's management team includes the following people:

Mr. Irwin D. Simon, CEO & Chairman (Age 62, Pay $6.54M)
Mr. Carl A. Merton, Chief Financial Officer
Dr. Christelle Gedeon L.L.B., Ph.D., Chief Legal Officer & Corp. Sec.
Mr. James R. Meiers, Chief Operating Officer of Aphria Leamington
Ms. Denise Menikheim Faltischek, Chief Strategy Officer & MD of Aphria Germany (Age 48, Pay $562.35k)
Mr. John B. Sadler, VP of Investor Relations
Mr. Bernard Yeung, Sr. VP of Sales & Marketing
Mr. Victor Neufeld, Special Advisor (Age 67)
Mr. Cole Cacciavillani, Special Advisor (Age 66)
Mr. Randy Daigneau, Sr. VP of Supply Chain

Who are some of Aphria's key competitors?

Some companies that are related to Aphria include MERCK Kommanditgesellschaft auf Aktien (MRK), Bausch Health Companies (BHC), Canopy Growth (WEED), Evotec (EVT), Hikma Pharmaceuticals (HIK), Leaf Mobile (LEAF), Aurora Cannabis (ACB), HEXO (HEXO), OrganiGram (OGI), Knight Therapeutics (GUD), HLS Therapeutics (HLS), Benchmark (BMK), Amryt Pharma (AMYT), The Supreme Cannabis (FIRE) and ICC Labs (ICC).
View all of APHA's competitors.

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON).

What is Aphria's stock symbol?

Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."

How do I buy shares of Aphria?

Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately C$16.55.

How much money does Aphria make?

Aphria has a market capitalization of C$5.24 billion and generates C$611.06 million in revenue each year.

How many employees does Aphria have?

Aphria employs 1,200 workers across the globe.

What is Aphria's official website?

The official website for Aphria is www.aphria.com.

Where are Aphria's headquarters?

Aphria is headquartered at 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada.

How can I contact Aphria?

Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.

This page was last updated on 6/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here